|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-2-24
|
|
pubmed:abstractText |
The number of mitoses and, thus, the proliferative capacity of a tumor is one of the most crucial variables for tumor grading. The Ki-67 nuclear antigen may be considered as an alternative to mitotic counts in grading schemes and as a single parameter that can be used in fine-needle aspirates and small biopsies.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:Castiglione-GertschMonicaM,
pubmed-author:CoatesAlan SAS,
pubmed-author:CollinsJohnJ,
pubmed-author:GelberRichard DRD,
pubmed-author:GoldhirschAronA,
pubmed-author:GolouhRastkoR,
pubmed-author:GustersonBarry ABA,
pubmed-author:International Breast Cancer Study Group,
pubmed-author:MurraySusanS,
pubmed-author:PriceKarenK,
pubmed-author:TrihiaHelenH
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1321-31
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
|
|
pubmed:affiliation |
International Breast Cancer Study Group Pathology Center, Western Infirmary, Glasgow, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
